Craneware Exceeds FY25 Expectations with Strong Revenue and Profit Growth

Craneware ( (GB:CRW) ) has provided an announcement.

Craneware plc reported strong financial performance for FY25, with revenue and profitability surpassing market expectations. The company achieved a 12% increase in adjusted EBITDA and a 9% rise in revenue, driven by sales momentum and recurring revenue streams from its Trisus Platform. The partnership with Microsoft and the focus on AI development are expected to enhance market penetration, while strong cash reserves and reduced debt position Craneware well for future growth in the US healthcare market.

The most recent analyst rating on (GB:CRW) stock is a Buy with a £28.00 price target. To see the full list of analyst forecasts on Craneware stock, see the GB:CRW Stock Forecast page.

Spark’s Take on GB:CRW Stock

According to Spark, TipRanks’ AI Analyst, GB:CRW is a Outperform.

Craneware’s strong financial performance and positive technical indicators contribute significantly to its overall stock score. However, the high P/E ratio suggests potential overvaluation, which tempers the score. The recent corporate event is a positive but minor influence on the stock’s perception.

To see Spark’s full report on GB:CRW stock, click here.

More about Craneware

The Craneware Group, a leader in healthcare financial and operational transformation, offers advanced technologies through its Trisus cloud ecosystem to optimize healthcare organizations’ performance. As a trusted Microsoft partner, Craneware provides solutions that simplify healthcare finance complexities, positioning itself as a strategic partner in the industry.

Average Trading Volume: 71,572

Technical Sentiment Signal: Strong Buy

Current Market Cap: £794.9M

For an in-depth examination of CRW stock, go to TipRanks’ Overview page.